In this expert perspective from Hawaiian Eye 2024, Rishi P. Singh, MD, said one of the biggest changes in retinal vein occlusion has been the advancement in understanding of how many patients are affected by the disease.
Socioeconomic and demographic differences can play a role in outcomes.
“One of the things we’ve learned from a lot of the registry studies is that these patients are very, very different from each other,” Singh said. “Certainly, our therapies are great, but not optimal, and we really need new therapies in this area (Read more...)